Page last updated: 2024-11-13

crotogoudin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

crotogoudin: has antineoplastic activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72945874
MeSH IDM000609035

Synonyms (10)

Synonym
crotogoudin
DTXSID001104158
2h-7a,10-ethanonaphtho[8a,1-b]pyran-2,8(9h)-dione, octahydro-4a-methyl-9-methylene-5-(1-methylethenyl)-, (4ar,5r,7as,10s,11ar)-
(4ar,5r,7as,10s,11ar)-octahydro-4a-methyl-9-methylene-5-(1-methylethenyl)-2h-7a,10-ethanonaphtho[8a,1-b]pyran-2,8(9h)-dione
unii-pf2yff2459
(4ar,5r,7as,10s,11ar)-octahydro-4a-methyl-9-methylene-5-(1-methylethenyl)-2h-7a,10-ethanonaphtho(8a,1-b)pyran-2,8(9h)-dione
1252665-39-6
pf2yff2459 ,
2h-7a,10-ethanonaphtho(8a,1-b)pyran-2,8(9h)-dione, octahydro-4a-methyl-9-methylene-5-(1-methylethenyl)-, (4ar,5r,7as,10s,11ar)-
ent-crotogoudin
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]